Posted : 2020-12-31 15:04
Updated : 2021-02-18 19:22
Outgoing Celltrion Chairman Seo Jung-jin speaks during a biotechnology industry conference in Incheon, Nov. 18. Hankook Ilbo photo by Wang Tae-seog
Biotech developing cocktail treatment for variants
By Nam Hyun-woo
After Celltrion Chairman Seo Jung-jin stepped down from his post at the biopharmaceutical giant, attention is being paid to the future shape of the company s leadership.
According to Celltrion, Seo has not worked as chairman since Dec. 31, following an earlier promise that he would wrap up his stint at the company by the end of 2020. During a local investment forum in October, the Celltrion founder said he would start a venture company on ubiquitous healthcare, an emerging area of medical technology.
Posted : 2020-12-31 15:04
Updated : 2021-02-18 19:22
Outgoing Celltrion Chairman Seo Jung-jin speaks during a biotechnology industry conference in Incheon, Nov. 18. Hankook Ilbo photo by Wang Tae-seog
Biotech developing cocktail treatment for variants
By Nam Hyun-woo
After Celltrion Chairman Seo Jung-jin stepped down from his post at the biopharmaceutical giant, attention is being paid to the future shape of the company s leadership.
According to Celltrion, Seo has not worked as chairman since Dec. 31, following an earlier promise that he would wrap up his stint at the company by the end of 2020. During a local investment forum in October, the Celltrion founder said he would start a venture company on ubiquitous healthcare, an emerging area of medical technology.